日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants

T细胞双特异性抗体在淋巴结阳性乳腺癌中的应用:MHC I类缺失变异体的新治疗途径

Messaoudene, M; Mourikis, T P; Michels, J; Fu, Y; Bonvalet, M; Lacroix-Trikki, M; Routy, B; Fluckiger, A; Rusakiewicz, S; Roberti, M P; Cotteret, S; Flament, C; Poirier-Colame, V; Jacquelot, N; Ghiringhelli, F; Caignard, A; Eggermont, A M M; Kroemer, G; Marabelle, A; Arnedos, M; Vicier, C; Dogan, S; Jaulin, F; Sammut, S-J; Cope, W; Caldas, C; Delaloge, S; McGranahan, N; André, F; Zitvogel, L

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

一种靶向治疗囊性纤维化的新型疗法:半胱胺联合表没食子儿茶素没食子酸酯,通过自噬依赖性途径挽救 II 类突变 CFTR 蛋白。

Tosco, A; De Gregorio, F; Esposito, S; De Stefano, D; Sana, I; Ferrari, E; Sepe, A; Salvadori, L; Buonpensiero, P; Di Pasqua, A; Grassia, R; Leone, C A; Guido, S; De Rosa, G; Lusa, S; Bona, G; Stoll, G; Maiuri, M C; Mehta, A; Kroemer, G; Maiuri, L; Raia, V

The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade

溶瘤肽LTX-315克服了癌症对CTLA4检查点阻断免疫疗法的耐药性

Yamazaki, T; Pitt, J M; Vétizou, M; Marabelle, A; Flores, C; Rekdal, Ø; Kroemer, G; Zitvogel, L

Dying cell recognition shapes the pathophysiology of cell death

垂死细胞的识别塑造了细胞死亡的病理生理过程。

Kroemer, G

Autophagy in stress and disease

自噬在应激和疾病中的作用

Maiuri, M Chiara; Kroemer, G

Ferroptosis in p53-dependent oncosuppression and organismal homeostasis

p53依赖性肿瘤抑制和机体稳态中的铁死亡

Galluzzi, L; Bravo-San Pedro, J M; Kroemer, G

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

细胞死亡的必要方面与辅助方面:2015 年 NCCD 的建议

Galluzzi, L; Bravo-San Pedro, J M; Vitale, I; Aaronson, S A; Abrams, J M; Adam, D; Alnemri, E S; Altucci, L; Andrews, D; Annicchiarico-Petruzzelli, M; Baehrecke, E H; Bazan, N G; Bertrand, M J; Bianchi, K; Blagosklonny, M V; Blomgren, K; Borner, C; Bredesen, D E; Brenner, C; Campanella, M; Candi, E; Cecconi, F; Chan, F K; Chandel, N S; Cheng, E H; Chipuk, J E; Cidlowski, J A; Ciechanover, A; Dawson, T M; Dawson, V L; De Laurenzi, V; De Maria, R; Debatin, K-M; Di Daniele, N; Dixit, V M; Dynlacht, B D; El-Deiry, W S; Fimia, G M; Flavell, R A; Fulda, S; Garrido, C; Gougeon, M-L; Green, D R; Gronemeyer, H; Hajnoczky, G; Hardwick, J M; Hengartner, M O; Ichijo, H; Joseph, B; Jost, P J; Kaufmann, T; Kepp, O; Klionsky, D J; Knight, R A; Kumar, S; Lemasters, J J; Levine, B; Linkermann, A; Lipton, S A; Lockshin, R A; López-Otín, C; Lugli, E; Madeo, F; Malorni, W; Marine, J-C; Martin, S J; Martinou, J-C; Medema, J P; Meier, P; Melino, S; Mizushima, N; Moll, U; Muñoz-Pinedo, C; Nuñez, G; Oberst, A; Panaretakis, T; Penninger, J M; Peter, M E; Piacentini, M; Pinton, P; Prehn, J H; Puthalakath, H; Rabinovich, G A; Ravichandran, K S; Rizzuto, R; Rodrigues, C M; Rubinsztein, D C; Rudel, T; Shi, Y; Simon, H-U; Stockwell, B R; Szabadkai, G; Tait, S W; Tang, H L; Tavernarakis, N; Tsujimoto, Y; Vanden Berghe, T; Vandenabeele, P; Villunger, A; Wagner, E F; Walczak, H; White, E; Wood, W G; Yuan, J; Zakeri, Z; Zhivotovsky, B; Melino, G; Kroemer, G

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines

体液免疫反应对蒽环类药物介导的抗肿瘤作用的贡献

Hannani, D; Locher, C; Yamazaki, T; Colin-Minard, V; Vetizou, M; Aymeric, L; Viaud, S; Sanchez, D; Smyth, M J; Bruhns, P; Kroemer, G; Zitvogel, L

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling

自噬抑制在体外可增强放射敏感性,但由于免疫信号传导不足,在体内却会降低放射反应。

Ko, A; Kanehisa, A; Martins, I; Senovilla, L; Chargari, C; Dugue, D; Mariño, G; Kepp, O; Michaud, M; Perfettini, J-L; Kroemer, G; Deutsch, E

Systems biology of cisplatin resistance: past, present and future

顺铂耐药性的系统生物学:过去、现在和未来

Galluzzi, L; Vitale, I; Michels, J; Brenner, C; Szabadkai, G; Harel-Bellan, A; Castedo, M; Kroemer, G